These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

661 related items for PubMed ID: 26592322

  • 1. Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-β/smad2/3 and NF-κB signaling pathways.
    Xu P, Zhang Y, Liu Y, Yuan Q, Song L, Liu M, Liu Z, Yang Y, Li J, Li D, Ren G.
    Toxicol Appl Pharmacol; 2016 Jan 01; 290():43-53. PubMed ID: 26592322
    [Abstract] [Full Text] [Related]

  • 2. NLRC5 regulates TGF-β1-induced proliferation and activation of hepatic stellate cells during hepatic fibrosis.
    Xu T, Ni MM, Xing-Li, Li XF, Meng XM, Huang C, Li J.
    Int J Biochem Cell Biol; 2016 Jan 01; 70():92-104. PubMed ID: 26592197
    [Abstract] [Full Text] [Related]

  • 3. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H, Dong F, Li G, Niu M, Zhang C, Han Y, He L, Yin P, Wang B, Sang X, Li R, Wang J, Bai Z, Xiao X.
    J Ethnopharmacol; 2018 Jan 10; 210():232-241. PubMed ID: 28864168
    [Abstract] [Full Text] [Related]

  • 4. Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation.
    Zhou Y, Tong X, Ren S, Wang X, Chen J, Mu Y, Sun M, Chen G, Zhang H, Liu P.
    J Ethnopharmacol; 2016 Aug 22; 190():83-90. PubMed ID: 27282665
    [Abstract] [Full Text] [Related]

  • 5. Smad2 increases the apoptosis of activated human hepatic stellate cells induced by TRAIL.
    Xu F, Zhou D, Meng X, Wang X, Liu C, Huang C, Li J, Zhang L.
    Int Immunopharmacol; 2016 Mar 22; 32():76-86. PubMed ID: 26802603
    [Abstract] [Full Text] [Related]

  • 6. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
    Yang JH, Kim SC, Kim KM, Jang CH, Cho SS, Kim SJ, Ku SK, Cho IJ, Ki SH.
    Eur J Pharmacol; 2016 Jul 15; 783():92-102. PubMed ID: 27151496
    [Abstract] [Full Text] [Related]

  • 7. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
    Xiang D, Zou J, Zhu X, Chen X, Luo J, Kong L, Zhang H.
    Phytomedicine; 2020 Nov 15; 78():153294. PubMed ID: 32771890
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pin1 induction in the fibrotic liver and its roles in TGF-β1 expression and Smad2/3 phosphorylation.
    Yang JW, Hien TT, Lim SC, Jun DW, Choi HS, Yoon JH, Cho IJ, Kang KW.
    J Hepatol; 2014 Jun 15; 60(6):1235-41. PubMed ID: 24530597
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W, Wang LW, Shi JZ, Gong ZJ.
    Hepatobiliary Pancreat Dis Int; 2009 Jun 15; 8(3):300-8. PubMed ID: 19502172
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Curcumol induces HSC-T6 cell death through suppression of Bcl-2: involvement of PI3K and NF-κB pathways.
    Chen G, Wang Y, Li M, Xu T, Wang X, Hong B, Niu Y.
    Eur J Pharm Sci; 2014 Dec 18; 65():21-8. PubMed ID: 25220584
    [Abstract] [Full Text] [Related]

  • 18. Knockdown of LOXL1 inhibits TGF-β1-induced proliferation and fibrogenesis of hepatic stellate cells by inhibition of Smad2/3 phosphorylation.
    Ma L, Zeng Y, Wei J, Yang D, Ding G, Liu J, Shang J, Kang Y, Ji X.
    Biomed Pharmacother; 2018 Nov 18; 107():1728-1735. PubMed ID: 30257391
    [Abstract] [Full Text] [Related]

  • 19. Ursodeoxycholyl lysophosphatidylethanolamide attenuates hepatofibrogenesis by impairment of TGF-β1/Smad2/3 signalling.
    Pathil A, Mueller J, Ludwig JM, Wang J, Warth A, Chamulitrat W, Stremmel W.
    Br J Pharmacol; 2014 Nov 18; 171(22):5113-26. PubMed ID: 25041068
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.